Kirchhof K, Sikinger M, Welzel T, Zoubaa S, Sartor K
Abteilung Neuroradiologie, Neurologische Klinik, Universitätsklinikum Heidelberg.
Rofo. 2004 Jan;176(1):98-105. doi: 10.1055/s-2004-814671.
It is known from autopsy studies that thromboembolic stroke can be caused by red, white and mixed clots. We therefore examined whether the efficacy of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) depends on the proportions of fibrin and erythrocytes within thromboembolic material.
In 23 rabbits intraarterial thrombolysis with 3 mg rt-PA/kg body weight was started 30 minutes after middle cerebral artery occlusion with either red or white autologous emboli 20 hours old. 20 rabbits served as control. Cerebral perfusion was monitored by MRI.
rt-PA enhanced lysis of red but not of white emboli and decreased the infarct volume only if vascular occlusion was due to red emboli (p <.01). Cerebral perfusion improved only in the red treatment group where the normalized first moment (NFM) decreased (p <.05) and the relative regional cerebral blood volume (rrCBV) reached normal values (p <.05).
We suggest that in our animal model the efficacy of thrombolysis increases with the proportion of erythrocytes within thromboembolic material and decreases with its content of fibrin. lf these findings would also be applicable to patients, pretherapeutic estimation of the efficacy of thrombolysis might become feasible because the CT values of red and white thrombi differ.
尸检研究表明,红色、白色和混合性血栓均可导致血栓栓塞性中风。因此,我们研究了重组组织型纤溶酶原激活剂(rt-PA)溶栓的疗效是否取决于血栓栓塞物质中纤维蛋白和红细胞的比例。
23只兔子在大脑中动脉闭塞后30分钟,用3mg rt-PA/kg体重进行动脉内溶栓,闭塞栓子为20小时的自体红色或白色栓子。20只兔子作为对照。通过MRI监测脑灌注。
rt-PA可增强红色栓子的溶解,但对白色栓子无效,且仅当血管闭塞由红色栓子引起时,梗死体积才会减小(p<.01)。仅在红色栓子治疗组脑灌注得到改善,其中标准化一阶矩(NFM)降低(p<.05),相对局部脑血容量(rrCBV)达到正常值(p<.05)。
我们认为,在我们的动物模型中,溶栓疗效随血栓栓塞物质中红细胞比例的增加而提高,随纤维蛋白含量的增加而降低。如果这些发现也适用于患者,那么溶栓疗效的治疗前评估可能变得可行,因为红色和白色血栓的CT值不同。